Lepore JJ, Olson E, Demopoulos L, Haws T, Fang Z, Barbour AM, Fossler M, Davila-Roman VG, Russell SD, Gropler RJ (2016) Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
Furthermore, the existence of endogenous ligands that bind to these receptors (termed endocannabinoids) has also been demonstrated, pointing towards the pharmacological and physiological importance of cannabinoid receptors
No MT-1 requires concurrent UV exposure to produce visible pigmentation
A healthy lifestyle goes a long way in keeping your body feeling strong and resilient to pain
94.4K views 72 authors 14 articles Disease-modifying approaches in type 1 diabetes 94.4K views 72 authors 14 articles Loading